Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: THE JOHNS HOPKINS UNIVERSITY
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-05-05 to 2026-08-01
Current total value of award: $3628715
Description: PHASE I STUDY OF THE INFECTIVITY, SAFETY AND IMMUNOGENICITY OF TWO RECOMBINANT, LIVE-ATTENUATED, BOVINE/HUMAN, PARAINFLUENZA VIRUS TYPE 3 (B/HPIV3) VECTOR VACCINES EXPRESSING THE FUSION GLYCOPROTEIN OF HUMAN METAPNEUMOVIRUS, DELIVERED BY NASAL SPRAY